Skip to content
Trial Eligibility
Menu

Prostate Cancer Clinical Trials near Seattle, WA

64 studies for Prostate Cancer are recruiting at 133 sites within 50 miles of Seattle, Washington, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Prostate Cancer trials in the US or all trials near Seattle.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Prostate Cancer studies enrolling near Seattle

Showing the 50 nearest of 64 studies.
  1. Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

    NCT05806515

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: FHCC South Lake Union (Seattle, WA); Fred Hutchinson Cancer Research Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    13 sites within 50 mi
  2. Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

    NCT06592924

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: FHCC at Northwest Hospital (Seattle, WA); Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    13 sites within 50 mi
  3. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    NCT04423211

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: FHCC at Northwest Hospital (Seattle, WA); Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    11 sites within 50 mi
  4. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Swedish Medical Center-Ballard Campus (Seattle, WA); Swedish Medical Center-Cherry Hill (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  5. A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

    NCT06629779

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Fred Hutchinson Cancer Center (Seattle, WA); Harborview Medical Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  6. Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

    NCT03678025

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: FHCC South Lake Union (Seattle, WA); FHCC at Northwest Hospital (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  7. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    NCT05946213

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: FHCC at Northwest Hospital (Seattle, WA); Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  8. A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    NCT06842498

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Fred Hutchinson Cancer Center (Seattle, WA); University of Washington Medical Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  9. A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

    NCT07164443

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Fred Hutchinson Cancer Research Center (Seattle, WA); University of Washington (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  10. Prostate Active Surveillance Study

    NCT00756665

    • Observational
    • Ages 21 years and older
    • Sex: Male

    Nearest sites: University of Washington (Seattle, WA); Veterans Affairs Puget Sound Health Care System (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

    NCT04104776

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Fred Hutchinson Cancer Center (Seattle, WA); Swedish Cancer Institute (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    NCT04606446

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Swedish Cancer Institute (Seattle, WA); Swedish Medical Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

    NCT06855277

    • Phase 3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest sites: Swedish Medical Center (Seattle, WA); Northwest Medical Specialties (Tacoma, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

    NCT06925737

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Fred Hutchinson Cancer Center ( Site 0060) (Seattle, WA); VA Puget Sound Health Care System ( Site 0054) (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  15. A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT07225946

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Fred Hutch Cancer Center Sloan Clinic 2 (Seattle, WA); Fred Hutchinson Cancer Research Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

    NCT01050504

    • Observational
    • Ages 18 years and older
    • Sex: Male
    • Accepts healthy volunteers

    Nearest site: Fred Hutch/University of Washington Cancer Consortium (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

    NCT04038502

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: VA Puget Sound Health Care System Seattle Division, Seattle, WA (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study

    NCT04175431

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Fred Hutch/University of Washington Cancer Consortium (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT04221542

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

    NCT04363164

    • Phase 2
    • Ages 18 to 90 years
    • Sex: Male

    Nearest site: University of Washington/Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

    NCT04472338

    • Observational
    • Ages 40 years and older
    • Sex: Male
    • Accepts healthy volunteers

    Nearest site: Fred Hutch/University of Washington Cancer Consortium (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

    NCT04489719

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Fred Hutch/University of Washington Cancer Consortium (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    NCT04585750

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest site: University of Washington, Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Precision-Based Genomics in Prostate Cancer

    NCT04706663

    • Observational
    • Ages 18 to 120 years
    • Sex: Male

    Nearest site: University of Washington (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

    NCT04812366

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

    NCT04986423

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Seattle Cancer Care Alliance (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness

    NCT04995198

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Washington Medical Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

    NCT05011383

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: VA Puget Sound Health Care System Seattle Division, Seattle, WA (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. A Study of NX-1607 in Adults With Advanced Malignancies

    NCT05107674

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. Study of ORIC-944 in Patients With Metastatic Prostate Cancer

    NCT05413421

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Washington, Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

    NCT05422911

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: VA Puget Sound Health Care System (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

    NCT05593497

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: VA Puget Sound Health Care System Seattle Division, Seattle, WA (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

    NCT05652686

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutch Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial

    NCT05918263

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Fred Hutch/University of Washington Cancer Consortium (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

    NCT05983432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Washington Fred Hutchinson (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

    NCT05997615

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Investigational Site Number: 400 (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study

    NCT06039371

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Fred Hutch/University of Washington Cancer Consortium (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

    NCT06067841

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

    NCT06095089

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Swedish Medical Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

    NCT06111781

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Washington (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

    NCT06136624

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutchinson Cancer Center ( Site 0013) (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

    NCT06145633

    • Phase 2
    • Ages Any age
    • Sex: Male

    Nearest site: Fred Hutch/University of Washington Cancer Consortium (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

    NCT06236139

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Fred Hutch/University of Washington Cancer Consortium (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

    NCT06395519

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease

    NCT06526299

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Fred Hutch/University of Washington Cancer Consortium (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

    NCT06613100

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

    NCT06778863

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Fred Hutchinson Cancer Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

    NCT06780670

    • Phase 2/3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: Fred Hutchinson Cancer Research Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

    NCT06801236

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Fred Hutchinson Cancer Research Center (Seattle, WA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Prostate Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.